Color fundus photography of a 29-year-old male. (a, b) Initial presentation. (c, d) Two weeks. (e, f) Sixteen months after initial presentation
In ICGA, acute lesions show hypocyanescence in the early phase (Fig. 1.4d) and become more defined in shape in the late phase (Fig. 1.4e). These hypocyanescent lesions are numerous than the lesions observed on funduscopy and FA. Unlike FA, deep choroidal vessels are visible within the active lesion during early phase of ICGA and no hypercyanescence develops in the late phase. These findings support the hypothesis that the active APMPPE lesions result from the choriocapillaris nonperfusion presumably due to inflammation (Hedges et al. 1979). The hypocyanescence becomes less defined and smaller in the late or resolved stage of the disease, as disappearance of the outer retina or RPE swelling, which support the alternative hypothesis suggesting the primary inflammation of the outer retina and RPE (Gass 1968).
Spaide reported that the early hypofluorescent areas observed on FA did not match up precisely with the RPE changes on fundus autofluorescence (FAF), which suggests that the presence of choriocapillaris perfusion defects (Spaide 2006). Meanwhile, the staining of the lesion in the late phase FA matched the lesions observed on FAF in shape and size. These findings also support that the hypothesis that the RPE abnormalities resulted from the choroidal abnormalities (Spaide 2006). As resolving, the placoid lesions contracts centripetally and develop pigmented core with a depigmented halo. On FAF, these lesions are observed as intense hyperautofluorescence surrounded by hypoautofluorescence. These autofluorescence changes follow the clinical appearance (Spaide 2006).
Differential Diagnosis
Diagnosis of APMPPE can be challenging because several diseases of different etiologies can also present with the similar clinical signs. The most challenging differential diagnosis might be SC, but clinical differentials do exist. SC usually starts from the optic disc and progresses in a serpentine fashion, while APMPPE lesions are always around the macula (Sudharshan et al. 2010; Annamalai et al. 2012). Scar formation is more prominent in SC and is not a characteristic feature in APMPPE. It can take up to a few years to develop signs in the fellow eye after unilateral involvement of SC lesion, while APMPPE is usually symmetrical in presentation (Annamalai et al. 2012).
Because of considerable overlap between APMPPE and SC, a term “Ampiginous choroiditis” has been used (Nussenblatt et al. 1996). However, some authors differentiate ampiginous choroiditis from SC and APMPPE based on the following points. Ampiginous choroiditis has smaller lesion than SC and APMPPE, approximately ½ disc area. Unlike SC, ampiginous choroiditis usually occurs in the mid-periphery and periphery, and the posterior pole may be involved later. Ampiginous choroiditis lesions are recurrent unlike APMPPE, and the active lesions show central hypofluorescence with hyperfluorescent margins in FA in contrast to the blocked fluorescence observed in APMPPE (Jyotirmay et al. 2010).
Management
In contrast to the previous reports with a good visual prognosis and a benign course (Gass 1968; Williams and Mieler 1989; Fitzpatrick and Robertson 1973), recent studies reported limited visual recovery in some patients (Wolf et al. 1991; Vianna et al. 1993; Fiore et al. 2009). The visual prognosis strongly depends on the presence of the foveal involvement at the initial presentation. Approximately 60% of the eyes have residual symptoms at the final visit (Fiore et al. 2009).
There is no definite guideline for the treatment of acute APMPPE. While some studies showed benefits of systemic corticosteroids (Deutman et al. 1972; Kirkham et al. 1972), others reported no change in prognosis despite treatment (Gass 1968; Annesley et al. 1973; Fitzpatrick and Robertson 1973). Some authors support the use of corticosteroids when there is macular involvement or central nervous system involvement (O’Halloran et al. 2001; Birnbaum et al. 2010; Brezin et al. 1995). El-Markaby and colleagues reported that the use of tumor necrosis factor blockers in severe cases of APMPPE resulted in significant visual improvement without recurrence (El-Markaby et al. 2012). In case of CNV development, anti-vascular endothelial growth factor agents have been found to be useful in treatment (Mavrakanas et al. 2010; Battaglia Parodi et al. 2010).